featured
Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-Exacerbated Respiratory Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
American Journal of Respiratory and Critical Care Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Omalizumab for Aspirin-Hypersensitivity and Leukotriene Overproduction in Aspirin-Exacerbated Respiratory Disease: A Randomized Trial
Am J Respir Crit Care Med 2020 Mar 06;[EPub Ahead of Print], H Hayashi, Y Fukutomi, C Mitsui, K Kajiwara, K Watai, Y Kamide, Y Nakamura, Y Hamada, Y Tomita, K Sekiya, T Tsuburai, K Izuhara, K Wakahara, N Hashimoto, Y Hasegawa, M TaniguchiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.